Literature DB >> 7713939

Characterization of a protein kinase C-delta (PKC-delta) ATP binding mutant. An inactive enzyme that competitively inhibits wild type PKC-delta enzymatic activity.

W Li1, J C Yu, D Y Shin, J H Pierce.   

Abstract

To investigate the function of protein kinase C (PKC)-delta, we mutated its ATP binding site by converting the invariant lysine in the catalytic domain (amino acid 376) to an arginine. Expression vectors containing wild type and mutant PKC-delta cDNAs were generated either with or without an influenza virus hemagglutinin epitope tag. After expression in 32D cells by transfection, the PKC-delta ATP binding mutant (PKC-delta K376R) was not able to phosphorylate itself or the PKC-delta pseudosubstrate region-derived substrate, indicating that PKC-delta K376R was an inactive enzyme. PKC activity was inhibited by 67% in 32D cells coexpressing both PKC-delta wild type (PKC-delta WT) and PKC-delta K376R when compared to 32D cells expressing only PKC-delta WT. Mixture of PKC-delta WT and PKC-delta K376R kinase sources in vitro also reduced the enzymatic activity of PKC-delta WT. These results suggest that PKC-delta K376R competes with PKC-delta WT and inhibits PKC-delta WT phosphorylation of its in vitro substrate. While PKC-delta WT overexpressed in 32D cells demonstrated 12-O-tetradecanoylphorbol-13-acetate (TPA)-dependent translocation from the cytosolic to the membrane fraction, PKC-delta K376R was exclusively localized in the membrane fraction even prior to TPA stimulation. Unlike PKC-delta WT which was phosphorylated on tyrosine residue(s) only after TPA treatment, PKC-delta K376R was constitutively phosphorylated on tyrosine residue(s). Although exposure of PKC-delta WT transfectants to TPA induced 32D monocytic differentiation, the 32D/PKC-delta K376R transfectants were resistant to TPA-induced differentiation. Thus, expression of active PKC-delta is required to mediate 32D monocytic differentiation in response to TPA stimulation.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7713939     DOI: 10.1074/jbc.270.14.8311

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  23 in total

1.  Formation of ternary complex of human biliverdin reductase-protein kinase Cδ-ERK2 protein is essential for ERK2-mediated activation of Elk1 protein, nuclear factor-κB, and inducible nitric-oxidase synthase (iNOS).

Authors:  Peter E M Gibbs; Tihomir Miralem; Nicole Lerner-Marmarosh; Cicerone Tudor; Mahin D Maines
Journal:  J Biol Chem       Date:  2011-11-07       Impact factor: 5.157

2.  Characterization of protein kinase C beta isoform's action on retinoblastoma protein phosphorylation, vascular endothelial growth factor-induced endothelial cell proliferation, and retinal neovascularization.

Authors:  Kiyoshi Suzuma; Noriko Takahara; Izumi Suzuma; Keiji Isshiki; Kohjiro Ueki; Michael Leitges; Lloyd Paul Aiello; George L King
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-22       Impact factor: 11.205

3.  Protein kinase C-delta is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation.

Authors:  W Li; Y X Jiang; J Zhang; L Soon; L Flechner; V Kapoor; J H Pierce; L H Wang
Journal:  Mol Cell Biol       Date:  1998-10       Impact factor: 4.272

4.  Protein kinase Cdelta amplifies ceramide formation via mitochondrial signaling in prostate cancer cells.

Authors:  Makoto Sumitomo; Motoi Ohba; Junichi Asakuma; Takako Asano; Toshio Kuroki; Tomohiko Asano; Masamichi Hayakawa
Journal:  J Clin Invest       Date:  2002-03       Impact factor: 14.808

5.  Protein kinase Cδ differentially regulates cAMP-dependent translocation of NTCP and MRP2 to the plasma membrane.

Authors:  Se Won Park; Christopher M Schonhoff; Cynthia R L Webster; M Sawkat Anwer
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-06-28       Impact factor: 4.052

6.  Regulation of inside-out β1-integrin activation by CDCP1.

Authors:  Sara G Pollan; Fangjin Huang; Jamie M Sperger; Joshua M Lang; Colm Morrissey; Anne E Cress; C Y Chu; Neil A Bhowmick; Sungyong You; Michael R Freeman; Danislav S Spassov; Mark M Moasser; William G Carter; Shakti Ranjan Satapathy; Kavita Shah; Beatrice S Knudsen
Journal:  Oncogene       Date:  2018-03-07       Impact factor: 9.867

7.  Protein kinase C-{delta} regulates the subcellular localization of Shc in H2O2-treated cardiomyocytes.

Authors:  Jianfen Guo; Lin Cong; Vitalyi O Rybin; Zoya Gertsberg; Susan F Steinberg
Journal:  Am J Physiol Cell Physiol       Date:  2010-08-04       Impact factor: 4.249

8.  Functional characterization of a serine/threonine protein kinase of Pseudomonas aeruginosa.

Authors:  S T Motley; S Lory
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

9.  Ste20-related protein kinase LOSK (SLK) controls microtubule radial array in interphase.

Authors:  Anton V Burakov; Olga N Zhapparova; Olga V Kovalenko; Liudmila A Zinovkina; Ekaterina S Potekhina; Nina A Shanina; Dieter G Weiss; Sergei A Kuznetsov; Elena S Nadezhdina
Journal:  Mol Biol Cell       Date:  2008-02-20       Impact factor: 4.138

10.  Overexpression of kinase-negative protein kinase Cdelta in pancreatic beta-cells protects mice from diet-induced glucose intolerance and beta-cell dysfunction.

Authors:  Anita M Hennige; Felicia Ranta; Isabel Heinzelmann; Martina Düfer; Diana Michael; Heidi Braumüller; Stefan Z Lutz; Reiner Lammers; Gisela Drews; Fatima Bosch; Hans-Ulrich Häring; Susanne Ullrich
Journal:  Diabetes       Date:  2009-10-13       Impact factor: 9.461

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.